1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HRH2 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA GRIP2 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA CST3 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA HLTF CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA MBP CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA TRIB2 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA ARHGDIG CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA USP13 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA CD300LF CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA ASCL5 CTRPv2 pan-cancer AAC 0.15 1e-05
Download CSV